Celldex Therapeutics (CLDX)
News
| May 25 | $CLDX the call premiums didn't just collapse after Wednesday, thats all I need to know by GreatWhiteHype |
| May 25 | @NHStocktrdr $CLDX this is a good long term stock. and you right about the big pipeline! I'm a buyer at these levels to average in! by BiopharmaPro |
| May 25 | $CLDX My exit plan here..between $9 and $12. 22,000 shares and holding.Don't care about the BS moves.Looking for the real $$ and we got pipe by NHStocktrdr |
| May 25 | RT @TTGCapital $CLDX close green, nice price axn eod, i'm bullish on this one as you all know.Bullish here to.We'll see a triple in due time by NHStocktrdr |
| May 25 | $CLDX building steam on the daily by DoinWerk |
| May 24 | WSJ article on $CLDX results doesn't say anything new but might bring attention to the name http://stks.co/3yiq by illinijill |
| May 24 | $CLDX heavy volume. i guess this could still runup past $5 by eom. by johnkelly |
| May 24 | Finding a Pathway to Approval Fool |
| May 24 | $CLDX sold another chunk @ 4.46. Ave $4.16 by DoinWerk |
| May 24 | Social Media Outlook for Thursday May 24 (HNZ, PAY, RIMM, NTAP) Benzinga |
| May 24 | Pre-Open Movers 5/24: (P) (HPQ) (PVH) Higher; (NTAP) (MTGE) (TIF) Lower (more...) Street Insider |
| May 24 | From Yesterday, Celldex's CDX-011 Demonstrates High Response Rates in Patients with M... |
| May 23 | After-Hours Movers 05/23: (P) (HPQ) (PVH) Higher; (MNOV) (NTAP) (CLDX) Lower Street Insider |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Diagnostic Substances
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celldex Therapeutics is up 19.68% over the last year vs S&P 500 Total Return up 1.18%, Rosetta Genomics down 86.85%, and MediciNova down 30.56%.
- CLDX Total Returns
- ^SPXTR Total Returns
- ROSG Total Returns
- MNOV Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CLDX related companies
Pro Strategies Featuring CLDX
Did Celldex Therapeutics make it into our Pro Portfolio Strategies?
CLDX Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other CLDX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CLDX | 4.50 | +0.02 | +0.45% | 257.22M |
| CLDT | 12.92 | -0.18 | -1.37% | 178.94M |
| CLD | 15.79 | +0.06 | +0.38% | 961.93M |
| CLCT | 14.43 | +0.05 | +0.35% | 116.88M |
| CLC | 49.40 | -0.34 | -0.68% | 2.483B |
| CL | 98.80 | -0.33 | -0.33% | 47.38B |
| CGEN | 3.80 | -0.25 | -6.17% | 131.90M |
| CGA | 3.37 | +0.04 | +1.20% | 90.79M |
| CFR | 57.51 | +0.00 | +0.00% | 3.525B |
| CFP | 5.43 | +0.01 | +0.18% |
